Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0038 | 0.338 | 0.431 | |
Echinococcus granulosus | protein kinase c epsilon type | 0.0057 | 0.6293 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0016 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0016 | 0 | 0.5 |
Loa Loa (eye worm) | CAMK/PKD protein kinase | 0.0038 | 0.3442 | 0.4157 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0053 | 0.5693 | 0.3432 |
Loa Loa (eye worm) | AGC/PKC/ALPHA protein kinase | 0.0025 | 0.1503 | 0.1816 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0029 | 0.2038 | 1 |
Echinococcus granulosus | protein kinase C gamma type | 0.004 | 0.3668 | 0.4795 |
Brugia malayi | C1-like domain containing protein | 0.0038 | 0.3442 | 0.5469 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1356 | 0.1637 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0057 | 0.6293 | 0.4348 |
Trypanosoma brucei | RNA helicase, putative | 0.0082 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.6053 | 0.7311 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.3275 | 0.3955 |
Echinococcus granulosus | protein kinase c iota type | 0.0045 | 0.441 | 0.6265 |
Echinococcus granulosus | Protein kinase C brain isozyme | 0.0053 | 0.5693 | 0.8809 |
Brugia malayi | protein kinase C3,putative | 0.003 | 0.2245 | 0.3567 |
Trichomonas vaginalis | AGC family protein kinase | 0.0016 | 0 | 0.5 |
Echinococcus multilocularis | serine threonine protein kinase | 0.004 | 0.3668 | 0.4795 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0042 | 0.4077 | 0.5606 |
Schistosoma mansoni | atypical protein kinase C | 0.0046 | 0.4594 | 0.1757 |
Brugia malayi | Protein kinase c protein 2 | 0.0039 | 0.3528 | 0.5606 |
Trichomonas vaginalis | AGC family protein kinase | 0.0016 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1356 | 0.1637 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.0053 | 0.5693 | 0.8809 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0057 | 0.6293 | 0.7601 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0057 | 0.6293 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.338 | 0.4082 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.125 | 0.151 |
Loa Loa (eye worm) | AGC/PKC/IOTA protein kinase | 0.0032 | 0.2429 | 0.2934 |
Brugia malayi | protein kinase C II. | 0.0057 | 0.6293 | 1 |
Loa Loa (eye worm) | CAMK/PKD protein kinase | 0.0025 | 0.1417 | 0.1712 |
Echinococcus multilocularis | protein kinase c iota type | 0.0045 | 0.441 | 0.6265 |
Onchocerca volvulus | 0.0056 | 0.6053 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.828 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.6053 | 0.7311 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.3505 | 0.4233 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.8078 | 0.9756 |
Brugia malayi | Phorbol esters/diacylglycerol binding domain | 0.0038 | 0.3442 | 0.5469 |
Onchocerca volvulus | 0.0039 | 0.3505 | 0.4576 | |
Trichomonas vaginalis | AGC family protein kinase | 0.0016 | 0 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase N2 | 0.0028 | 0.1913 | 0.1313 |
Trichomonas vaginalis | AGC family protein kinase | 0.0016 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0016 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.6053 | 0.7311 |
Trichomonas vaginalis | AGC family protein kinase | 0.0016 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0053 | 0.5693 | 0.3432 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ND (binding) | 0 nM | In vitro inhibition against human full length PARP protein; NT means not tested | ChEMBL. | 11063605 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.